Copertina

Bayesian analyses for research on Alzheimer's disease and related disorders—updating one's knowledge

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Stefan Teipel, Michael Lutz
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Technology‐based instrumental activities of daily living in persons with Alzheimer's disease and related disorders
di: Jared F. Benge, et al.
Pubblicazione: (2024)

Natural language processing in Alzheimer's disease research: Systematic review of methods, data, and efficacy
di: Arezo Shakeri, et al.
Pubblicazione: (2025)

Sensory changes in preclinical, prodromal, and clinical Alzheimer's disease and related dementias
di: Willa D. Brenowitz, et al.
Pubblicazione: (2026)

Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive decline
di: Stefan J. Teipel, et al.
Pubblicazione: (2024)

Fully automated MRI‐based analysis of the locus coeruleus in aging and Alzheimer's disease dementia using ELSI‐Net
di: Max Dünnwald, et al.
Pubblicazione: (2025)

Peripheral oxidative stress related biomarkers in Alzheimer's disease: A systematic review of their implications for diagnosis and disease monitoring
di: George Nkrumah Osei, et al.
Pubblicazione: (2026)

Mid‐ and late‐life depression increases risk of Alzheimer's disease and related dementias in veterans
di: Lay Kodama, et al.
Pubblicazione: (2026)

Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathology
di: Lara Blömeke, et al.
Pubblicazione: (2024)

A Bayesian analysis of diagnostic timelines across Alzheimer's disease, frontotemporal dementia, and other neurodegenerative conditions
di: Ananthan Ambikairajah, et al.
Pubblicazione: (2025)

Thalamus not basal forebrain is atrophied in non‐demented PSEN1 E280A carriers
di: Stefan Teipel, et al.
Pubblicazione: (2025)

Omega‐3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's disease dementia
di: Iolanda Lázaro, et al.
Pubblicazione: (2024)

Increased risk of infusion‐related reactions switching between monoclonal antibodies for Alzheimer's disease: A case series
di: Ganesh Gopalakrishna, et al.
Pubblicazione: (2026)

Interchangeability of CSF and PET to identify Alzheimer's disease pathology
di: Samantha C. Burnham, et al.
Pubblicazione: (2026)

Eye tracking as a diagnostic tool in Alzheimer's disease, mild cognitive impairment, and related dementias: a systematic review
di: Gustavo Luis Verón, et al.
Pubblicazione: (2025)

The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndrome
di: Julianne G. Clina, et al.
Pubblicazione: (2026)

The relative contribution of modifiable and non‐modifiable factors for determining cognition in mid‐life individuals at risk for late‐life Alzheimer's disease
di: Bolin Cao, et al.
Pubblicazione: (2026)

Age‐related macular degeneration severity and risk of Alzheimer's disease in older adults in a prospective, community‐based cohort study
di: Chloe A. Krakauer, et al.
Pubblicazione: (2026)

Divergent effects of age on imaging‐based ATN biomarkers and cognition in Alzheimer's disease
di: Lars Frings, et al.
Pubblicazione: (2025)

Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
di: María A. Rodríguez‐Santiago, et al.
Pubblicazione: (2024)

Disentangling the genetic underpinnings of neuropsychiatric symptoms in Alzheimer's disease in the Alzheimer's Disease Sequencing Project: Study design and methodology
di: Nicholas R. Ray, et al.
Pubblicazione: (2024)

Association between BrainAGE and Alzheimer's disease biomarkers
di: Yousaf Abughofah, et al.
Pubblicazione: (2025)

General practitioners’ perspectives on blood biomarkers for Alzheimer's disease
di: Thomas Claessen, et al.
Pubblicazione: (2025)

Atrophy signature for alpha‐synuclein copathology in Alzheimer's disease
di: Diana Esteller‐Gauxax, et al.
Pubblicazione: (2026)

Treating Alzheimer's disease in a person living with HIV
di: David B. Clifford, et al.
Pubblicazione: (2026)

Diagnostic performance of light reflex pupillometry in Alzheimer's disease
di: Mathias Holsey Gramkow, et al.
Pubblicazione: (2024)

From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach
di: Sonal Sukreet, et al.
Pubblicazione: (2024)

Brain‐derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia
di: Cassandra Marotta, et al.
Pubblicazione: (2025)

Diagnostic value of fluid‐based non‐amyloid biomarkers for Alzheimer's disease and related dementias in a clinic‐based cohort from South Asia
di: Faheem Arshad, et al.
Pubblicazione: (2025)

Alzheimer's disease neuropathology and longitudinal change in subjective cognitive complaints
di: Alisa Bannerjee, et al.
Pubblicazione: (2025)

Cerebrospinal fluid sclerostin levels in the early Alzheimer's disease stages
di: Manuela Dicarlo, et al.
Pubblicazione: (2026)

Cerebrospinal fluid soluble insulin receptor levels in Alzheimer's disease
di: Peter Thomas, et al.
Pubblicazione: (2024)

Longitudinal changes in functional capacity in frontotemporal dementia and Alzheimer's disease
di: David Foxe, et al.
Pubblicazione: (2024)

Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
di: Sofia Toniolo, et al.
Pubblicazione: (2024)

Elevated tau in the piriform cortex in Alzheimer's but not Parkinson's disease using PET‐MR
di: Hossein Moein Taghavi, et al.
Pubblicazione: (2024)

Accuracy of pattern‐based dementia diagnostic protocols: Using longitudinal data to infer etiology of Alzheimer's disease and related dementias compared to stroke or normal aging
di: Sean A. P. Clouston, et al.
Pubblicazione: (2025)

Automated remote speech‐based testing of individuals with cognitive decline: Bayesian agreement of transcription accuracy
di: Alexandra König, et al.
Pubblicazione: (2024)

Brain atrophy and clinical diagnosis independently predict default mode network failure across the Alzheimer's disease continuum
di: Mohammed Alghamdi, et al.
Pubblicazione: (2026)

Amyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's disease
di: Ying Xia, et al.
Pubblicazione: (2025)

Machine learning models of Alzheimer's disease spectrum using blood tests
di: Nicola Walter Falasca, et al.
Pubblicazione: (2025)

Effects of obesity on plasma biomarker and amyloid PET trajectories in Alzheimer's disease
di: Soheil Mohammadi, et al.
Pubblicazione: (2025)